In the 2000s, cost-effectiveness analysis said it was a bad use of money to send antiretroviral drugs to low-income countries—drugs that ended up saving millions of lives.
A broad array of international actors agrees that many developing countries desperately need to collect more tax revenue. But one part of the World Bank is pushing in the other direction.